The ultimate goal of today's cancer research is to create a comprehensive cancer treatment. The capacity of delivery methods and pharmacological conjugations for cancer treatment has piqued researchers' curiosity in recent studies. The terms targeted therapy, immunotherapy, and gene therapy are now the most common entries in the database of clinical trials for cancer therapies, indicating that they are the most popular approaches under consideration. Many advances have been made, but many more are anticipated to be made in the near future, resulting in an increasing number of ad hoc personalized therapy.
Important Alert:
X
Title : Deubiquitylase USP31 induces autophagy and promotes the progression in lung squamous cell carcinoma cells by stabilizing E2F1 expression
Qian Zhang, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, China
Title :
Luca Roncati, University of Modena and Reggio Emilia, Italy
Title :
Bene Ekine-Afolabi, ZEAB Therapeutic Ltd, United Kingdom
Title :
K.P.Mishra, Asian Association for Radiation Research, India